JPMORGAN CHASE & CO - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 29 filers reported holding BIOCEPT INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2022$189,000
-37.6%
81,367
-2.9%
0.00%
Q4 2021$303,000
+381.0%
83,775
+437.4%
0.00%
Q3 2021$63,000
+384.6%
15,589
+456.8%
0.00%
Q3 2020$13,0002,8000.00%
Other shareholders
BIOCEPT INC shareholders Q4 2020
NameSharesValueWeighting ↓
GLOBEFLEX CAPITAL L P 321,055$1,287,0000.28%
GSA CAPITAL PARTNERS LLP 92,639$371,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 51,967$208,0000.02%
Jump Financial, LLC 19,500$78,0000.01%
MARSHALL WACE, LLP 104,980$421,0000.00%
VANGUARD GROUP INC 658,586$2,640,0000.00%
Focused Wealth Management, Inc 1$00.00%
JANE STREET GROUP, LLC 11,181$45,0000.00%
UBS Group AG 1,984$8,0000.00%
OSAIC HOLDINGS, INC. 7,600$30,0000.00%
View complete list of BIOCEPT INC shareholders